Latest California Healthline Stories
Reporter’s Notebook: The Tale Of Theranos And The Mysterious Fire Alarm
Health care tech startup Theranos was riding high back in 2014. But when a reporter raised questions, its media reps circled the wagons.
Research Misconduct Allegations Shadow New CDC Head
Critics say the Trump administration failed to properly vet Dr. Robert Redfield as they attribute a pattern of “ethically and morally questionable behavior” to him.
California Hospitals Grapple With Shortage Of Powerful Opioid Painkillers
As supplies of injectable morphine, Dilaudid and fentanyl dwindle, hospitals are struggling to shore up supplies or find alternatives to keep their patients out of pain.
Bill Of The Month: For Toenail Fungus, A $1,500 Prescription
How a prescription wiped out one woman’s health reimbursement account, raising questions about prescription drug price tags and about how health care professionals deal (or don’t) with medical costs.
The Other Opioid Crisis: Hospital Shortages Lead To Patient Pain, Medical Errors
A nationwide shortage of injectable opioid painkillers has left hospitals scrambling to find alternatives — in some cases leading to dosage mistakes that may harm patients.
Opioid Maker Funds Efforts To Fight Addiction: Is It ‘Blood Money’ Or Charity?
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it — or at least salvage its own reputation.
Patients Overpay For Prescriptions 23% Of The Time, Analysis Shows
Researchers at the University of Southern California analyzed millions of prescriptions and concluded that close to a quarter paid copays that exceeded the cost of the drugs.
Rising Health Costs, Soaring Drug Prices, Confusing Bills! What’s A Consumer To Do?
KHN correspondent Shefali Luthra answered a wide variety of questions about health care in a Reddit “Ask Me Anything” chat.
Of ‘Miracles’ And Money: Why Hemophilia Drugs Are So Expensive
The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn’t worked to bring costs down. Sales amount to $4.6 billion annually in the U.S.
Nueva estrategia: hospitales internan a pacientes… en sus propias casas
Un enfoque común en Australia, Gran Bretaña y Canadá comienza a cobrar fuerza en el país: internar en sus propios hogares a los pacientes que no tienen condiciones de cuidado crítico.